FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315785133> ?p ?o ?g. }

• W4315785133 endingPage "e002781" @default.
• W4315785133 startingPage "e002781" @default.
• W4315785133 abstract "Background/purpose The manifestations of uveitis are well established in axial spondyloarthritis (ax-SpA), but not in psoriatic arthritis (PsA). We aimed to assess, in a large unselected series of PsA: (A) the frequency and clinical features of uveitis; (B) its association with PsA activity, the impact of disease and functional disability, and (C) its relationship with the biological treatment. In addition, a literature review was performed. Methods Retrospective longitudinal study of PsA patients from a single referral hospital. PsA was classified according to the CASPAR criteria, and uveitis was diagnosed by experienced ophthalmologists. Results We studied 406 patients with PsA (46.3±12.3 years). Uveitis was observed in 20 (4.9%). Uveitis was acute in all cases, anterior (80%), unilateral (80%) and recurrent (50%). Patients with uveitis had a higher prevalence of HLA-B27 (45% vs 7.5%, p<0.0001), sacroiliitis on MRI (25% vs 8.3% p=0.027), ocular surface pathology (10% vs 0.8%, p=0.021), and median PsA impact of Disease Score (5.9 (2.1–6.8) vs 1.25 (0.0–3.0), p=0.001) and Bath Ankylosing Spondylitis Functional Index (4 (1.6–5) vs 1.0 (0.0–3.5), p=0.01) than patients without uveitis. The exposure adjusted incidence rate (episodes/100 patients-year) of uveitis before versus after biological treatment decreased with anti-TNFα monoclonal antibodies (56.3 vs 9.4) and increased with etanercept (ETN) (6.03 vs 24.2) and secukinumab (SECU) (0 vs 50) (including only one patient treated in the last two cases). Conclusion The prevalence of uveitis in patients with PsA was about 5%. The pattern was similar to that observed in ax-SpA. Uveitis was associated with a worse quality of life and greater functional disability. The uveitis exposure adjusted incidence rate decreased with anti-TNFα monoclonal antibodies and increased with ETN and SECU." @default.
• W4315785133 created "2023-01-13" @default.
• W4315785133 creator A5012414361 @default.
• W4315785133 creator A5013522529 @default.
• W4315785133 creator A5015834521 @default.
• W4315785133 creator A5016922988 @default.
• W4315785133 creator A5028114633 @default.
• W4315785133 creator A5031531166 @default.
• W4315785133 creator A5047896320 @default.
• W4315785133 creator A5064034739 @default.
• W4315785133 creator A5073900189 @default.
• W4315785133 creator A5088970255 @default.
• W4315785133 creator A5089162825 @default.
• W4315785133 creator A5090329310 @default.
• W4315785133 date "2023-01-01" @default.
• W4315785133 modified "2023-10-17" @default.
• W4315785133 title "Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review" @default.
• W4315785133 cites W1502374914 @default.
• W4315785133 cites W1612727373 @default.
• W4315785133 cites W1678760907 @default.
• W4315785133 cites W1997929321 @default.
• W4315785133 cites W2000458455 @default.
• W4315785133 cites W2015406536 @default.
• W4315785133 cites W2020329616 @default.
• W4315785133 cites W2026691596 @default.
• W4315785133 cites W2045210947 @default.
• W4315785133 cites W2050172669 @default.
• W4315785133 cites W2052996963 @default.
• W4315785133 cites W2064877272 @default.
• W4315785133 cites W2074679120 @default.
• W4315785133 cites W2079920967 @default.
• W4315785133 cites W2081160332 @default.
• W4315785133 cites W2082186503 @default.
• W4315785133 cites W2088665851 @default.
• W4315785133 cites W2093604086 @default.
• W4315785133 cites W2102347458 @default.
• W4315785133 cites W2115678593 @default.
• W4315785133 cites W2128563477 @default.
• W4315785133 cites W2135779150 @default.
• W4315785133 cites W2139499737 @default.
• W4315785133 cites W2139624032 @default.
• W4315785133 cites W2155075837 @default.
• W4315785133 cites W2156351184 @default.
• W4315785133 cites W2258730682 @default.
• W4315785133 cites W2293474894 @default.
• W4315785133 cites W2461185310 @default.
• W4315785133 cites W2504234209 @default.
• W4315785133 cites W2593186219 @default.
• W4315785133 cites W2595900176 @default.
• W4315785133 cites W2626087684 @default.
• W4315785133 cites W271128620 @default.
• W4315785133 cites W2804672406 @default.
• W4315785133 cites W2883435593 @default.
• W4315785133 cites W2898369915 @default.
• W4315785133 cites W2921849012 @default.
• W4315785133 cites W2946823838 @default.
• W4315785133 cites W2979076705 @default.
• W4315785133 cites W2982115245 @default.
• W4315785133 cites W3010879168 @default.
• W4315785133 cites W3011426561 @default.
• W4315785133 cites W3013379292 @default.
• W4315785133 cites W3014202262 @default.
• W4315785133 cites W3022095567 @default.
• W4315785133 cites W3027539208 @default.
• W4315785133 cites W3042818036 @default.
• W4315785133 cites W3044048249 @default.
• W4315785133 cites W3049502487 @default.
• W4315785133 cites W3141101469 @default.
• W4315785133 cites W4283589104 @default.
• W4315785133 doi "https://doi.org/10.1136/rmdopen-2022-002781" @default.
• W4315785133 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36635002" @default.
• W4315785133 hasPublicationYear "2023" @default.
• W4315785133 type Work @default.
• W4315785133 citedByCount "4" @default.
• W4315785133 countsByYear W43157851332023 @default.
• W4315785133 crossrefType "journal-article" @default.
• W4315785133 hasAuthorship W4315785133A5012414361 @default.
• W4315785133 hasAuthorship W4315785133A5013522529 @default.
• W4315785133 hasAuthorship W4315785133A5015834521 @default.
• W4315785133 hasAuthorship W4315785133A5016922988 @default.
• W4315785133 hasAuthorship W4315785133A5028114633 @default.
• W4315785133 hasAuthorship W4315785133A5031531166 @default.
• W4315785133 hasAuthorship W4315785133A5047896320 @default.
• W4315785133 hasAuthorship W4315785133A5064034739 @default.
• W4315785133 hasAuthorship W4315785133A5073900189 @default.
• W4315785133 hasAuthorship W4315785133A5088970255 @default.
• W4315785133 hasAuthorship W4315785133A5089162825 @default.
• W4315785133 hasAuthorship W4315785133A5090329310 @default.
• W4315785133 hasBestOaLocation W43157851331 @default.
• W4315785133 hasConcept C118487528 @default.
• W4315785133 hasConcept C120665830 @default.
• W4315785133 hasConcept C121332964 @default.
• W4315785133 hasConcept C126322002 @default.
• W4315785133 hasConcept C147483822 @default.
• W4315785133 hasConcept C16005928 @default.
• W4315785133 hasConcept C167135981 @default.
• W4315785133 hasConcept C188280979 @default.
• W4315785133 hasConcept C203014093 @default.

• next